Skip to content
  • Home
  • Medical Supplies
  • Medical Insurance
  • Healthy Lifestyle
  • Medical Treatment
  • Healthy Diet
  • Healthy Parenting
  • About Us
cdnaas

cdnaas

everything health

Limbix raises $15M for adolescent mental healthcare

Posted on December 9, 2021 By Sharika Soukup

Limbix, maker of a prescription digital therapeutic aimed at treating depression in teens, scooped up $15 million in Series A2 funding.

The round was led by GSR Ventures, with participation from Digital Garage, Storm Ventures, Bixink, DN Capital, Korean Investment Partners, E& Investment, Gaingels, MVP, Operator Partners, Mana Ventures and Pacific Health Ventures.

Limbix announced its $9 million Series A in May 2020. The company said its A2 brings its total raise to $31 million.

WHAT IT DOES

Limbix is the creator of SparkRx, a prescription digital therapeutic that uses the principles of cognitive behavioral therapy to address depression in teens and young adults ages 13 to 22. It was released in October as part of the FDA’s relaxed regulatory requirements for digital health devices treating psychiatric disorders during the pandemic. 

“We are incredibly grateful to our investors for their support as we work to build evidence-based prescription digital therapeutics to address the mental health crisis head-on, improving access to treatment for adolescents and ensuring care is delivered when it is needed most,” CEO Ben Lewis said in a statement.

“The mental health crisis for children and young adults has reached an emergency level, exacerbated by the challenges and disruption caused by the COVID-19 pandemic. As the need for mental health treatment continues to grow, we aim to provide physicians with safe, effective technology-based resources that can immediately address their patient’s mental health needs across an array of adolescent conditions.”

WHAT IT’S FOR

The company plans to use the capital to commercialize SparkRx, and to expand its staff to about 60 workers by the middle of next year.

The larger staff will allow Limbix to speed development and testing of new digital therapeutics for other mental health disorders common among teens.

MARKET SNAPSHOT

Mental and behavioral healthcare is a hot topic in digital health. According to Rock Health’s Q3 analysis, mental health continued to be the leading clinical area for investors, bringing in $3.1 billion so far this year.

Other players in pediatric and adolescent behavioral health include BeMe Health, which recently raised $7 million in seed funding; Brightline, which is planning a program for children with autism spectrum disorder; and DotCom Therapy and Goodside Health, which recently partnered to increase access to mental healthcare in schools. 

https://www.mobihealthnews.com/news/limbix-raises-15m-adolescent-mental-healthcare

Medical Supplies Tags:15M, adolescent, healthcare, Limbix, Mental, raises

Post navigation

Previous Post: cbdMD : Is Hemp Oil The Same As CBD Oil…
Next Post: How to get a free rapid COVID-19 test with health insurance

More Related Articles

Wholesome Halloween Treats & Snack Concepts Medical Supplies
Three Forces Driving The Consumerization Of Healthcare Medical Supplies
Dependable Lab Devices Supplier for Good quality Solutions Medical Supplies
NC Senate Health Care Committee meets to discuss Medicaid expansion bill :: WRAL.com Medical Supplies
Invisible until the pandemic, family caregivers are now on the front lines Medical Supplies
The Fact About Operating Whilst Suffering with Perimenopause Medical Supplies

Recent Posts

  • Pediatric Crash Cart Medications
  • Living a Balanced Everyday living – The 5 Components to a Nutritious Life-style
  • Boosting Children to Become Successful Customers of Culture
  • Why Does My Well being Insurance policy Want Me To Fill Out A Type Soon after I’ve Been Hurt In An Accident?
  • Is a Vegan Diet Better For Your Hair and Pores and skin?

Archives

  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021

Copyright © 2023 cdnaas.

Powered by PressBook Green WordPress theme